Kestra Medical Technologies, Ltd. (KMTS)
NASDAQ: KMTS · Real-Time Price · USD
15.52
-0.98 (-5.94%)
Aug 1, 2025, 11:45 AM - Market open

KMTS Income Statement

Millions USD. Fiscal year is May - Apr.
Fiscal Year
FY 2025FY 2024FY 2023FY 2021FY 2020
Period Ending
Apr '25 Apr '24 Apr '23 Apr '21 Apr '20
59.8227.817.63--
Revenue Growth (YoY)
115.05%264.54%---
Cost of Revenue
35.6127.4518.28--
Gross Profit
24.210.36-10.65--
Selling, General & Admin
114.9469.9454.0113.96.52
Research & Development
15.6515.4915.7618.8122.8
Operating Expenses
130.5985.4369.7732.7129.32
Operating Income
-106.38-85.06-80.42-32.71-29.32
Interest Expense
-7.73-6.23-5.63-1.17-
Interest & Investment Income
3.2----
Other Non Operating Income (Expenses)
-2.77-0.091.83-0.04-
EBT Excluding Unusual Items
-113.68-91.38-84.22-33.91-29.32
Other Unusual Items
--2.72---
Pretax Income
-113.68-94.1-84.22-33.91-29.32
Income Tax Expense
0.140.020.020.190.15
Net Income
-113.81-94.12-84.24-34.1-29.47
Preferred Dividends & Other Adjustments
12.326.722.5--
Net Income to Common
-126.14-100.84-86.74-34.1-29.47
Shares Outstanding (Basic)
2520000
Shares Outstanding (Diluted)
2520000
Shares Change (YoY)
23.63%18693.84%---
EPS (Basic)
-5.13-5.07-819.76-322.29-278.50
EPS (Diluted)
-5.13-5.07-819.76-322.29-278.50
Free Cash Flow
-101.2-84.75-85.1-30.23-30.53
Free Cash Flow Per Share
-4.12-4.26-804.32-285.72-288.49
Gross Margin
40.48%1.30%-139.59%--
Operating Margin
-177.84%-305.83%-1054.01%--
Profit Margin
-210.88%-362.56%-1136.79%--
Free Cash Flow Margin
-169.19%-304.70%-1115.37%--
EBITDA
-98.41-73.5-75.57-32.29-28.84
EBITDA Margin
-164.52%-264.27%---
D&A For EBITDA
7.9711.564.860.420.48
EBIT
-106.38-85.06-80.42-32.71-29.32
EBIT Margin
-177.84%----
Updated Apr 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q